Zimmer Biomet
Zimmer accuses Stryker, ex-sales rep of ‘Trojan Horse’ poaching scheme
Zimmer’s Q4 profits surge
Zimmer’s board approves $1B share buyback
Abiomed loses IR exec to Boston Scientific | Personnel Moves
Susan Vissers Lisa, the former director of investor relations at Abiomed (NSDQ:ABMD), was named vice president of IR at Boston Scientific (NYSE:BSX).
MassDevice.com Q&A: Skyline Medical CEO Josh Kornberg
When John Kornberg joined then-BioDrain Medical in 2011 as an investor, the company had spent the past decade developing its Streamway surgical waste management device and getting clearance to commercialize it in the U.S. But, Kornberg told MassDevice.com recently, it was quickly apparent that BioDrain was stalled, unable to leverage its 510(k) clearance from the FDA into significant U.S. sales.
Zimmer and OrthoSensor team up to co-market sensor-assisted knee surgery
Orthopedics giant Zimmer (NYSE:ZMH) and OrthoSensor signed a co-marketing agreement pairing Zimmer’s NexGen knee systems with OrthoSensor’s Verasense technology.
Zimmer slides on Q3 profit slide, narrowed guidance
Zimmer gets a chance to reverse $27.6M loss over marketing video injury
Medical devices and the Great Deflation
The medical device industry has "lost" about $131 billion in revenues since the financial collapse of 2008, according to analysts at Ernst & Young.
The findings, taken from the audit firm’s annual "Pulse of the Industry" report, paint a glum picture for the medtech industry, once considered to be "recession proof."